| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/16/2022 | Inhibikase Therapeutics, Inc. | | Purchase | Common Stock | 5k | $0.80 | $4k | | 08/16/2022 |
| 05/27/2022 | Inhibikase Therapeutics, Inc. | | Purchase | Common Stock | 5k | $0.98 | $4.9k | | 05/27/2022 |
| 05/20/2022 | Inhibikase Therapeutics, Inc. | | Purchase | Common Stock | 10k | $0.60 | $6k | | 05/20/2022 |
| 03/07/2022 | Inhibikase Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 125k | $1.07 | $133.8k | | 03/07/2022 |
| 03/07/2022 | Inhibikase Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 125k | $1.07 | $133.8k | | 03/07/2022 |
| 01/03/2022 | Inhibikase Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 21.9k | $2.02 | $44.1k | | 01/03/2022 |
| 11/17/2021 | Inhibikase Therapeutics, Inc. | | Purchase | Common Stock | 17.6k | $1.98 | $34.8k | Domestic Partner | 11/17/2021 |
| 11/17/2021 | Inhibikase Therapeutics, Inc. | | Purchase | Common Stock | 1.1k | $1.97 | $2.2k | Domestic Partner | 11/17/2021 |
| 11/17/2021 | Inhibikase Therapeutics, Inc. | | Purchase | Common Stock | 3.2k | $1.96 | $6.2k | Domestic Partner | 11/17/2021 |
| 11/17/2021 | Inhibikase Therapeutics, Inc. | | Purchase | Common Stock | 1.3k | $1.94 | $2.6k | Domestic Partner | 11/17/2021 |
| 11/17/2021 | Inhibikase Therapeutics, Inc. | | Purchase | Common Stock | 400 | $1.93 | $772 | Domestic Partner | 11/17/2021 |
| 05/14/2021 | Inhibikase Therapeutics, Inc. | | Payment of Exercise | Common Stock | 16.9k | $4.59 | $77.7k | | 05/14/2021 |
| 05/14/2021 | Inhibikase Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 43.7k | $0.38 | $16.6k | | 05/14/2021 |
| 12/22/2020 | Inhibikase Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 100k | $10.00 | $1000k | | 12/22/2020 |